(Q44735547)

5 December 2017

Detection of high-level tetracycline resistance in clinical isolates of Helicobacter pylori using PCR-RFLP. (English)

1 reference

5 December 2017

0 references

1 reference

1

1 reference

5 December 2017

6

Ernst J Kuipers

1 reference

5 December 2017

Monique M Gerrits

2

1 reference

5 December 2017

Yune H B Benvengo

3

1 reference

5 December 2017

Marco Berning

4

1 reference

5 December 2017

Anita P O Godoy

5

1 reference

5 December 2017

Sergio Mendonça

7

1 reference

5 December 2017

Arnoud H M van Vliet

8

1 reference

5 December 2017

José Pedrazzoli

9

1 reference

5 December 2017

Johannes G Kusters

10

1 reference

5 December 2017

1 January 2004

1 reference

FEMS Immunology and Medical Microbiology

5 December 2017

1 reference

5 December 2017

40

1 reference

5 December 2017

57-61

1 reference

5 December 2017

1

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900277-3

5 December 2017

1 reference

7 January 2021

Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900277-3

7 January 2021

Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900277-3

7 January 2021

Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900277-3

7 January 2021

How to treat Helicobacter pylori. First-line, second-line, and future therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900277-3

7 January 2021

Helicobacter pylori therapy: first-line options and rescue regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900277-3

7 January 2021

Antimicrobial treatment of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900277-3

7 January 2021

The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900277-3

7 January 2021

Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900277-3

7 January 2021

Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900277-3

7 January 2021

Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900277-3

7 January 2021

Resistance of helicobacter pylori to metronidazole, tetracycline and amoxycillin.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900277-3

7 January 2021

16S rRNA mutation-mediated tetracycline resistance in Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900277-3

7 January 2021

Mutations in the 16S rRNA genes of Helicobacter pylori mediate resistance to tetracycline

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900277-3

7 January 2021

Emergence of tetracycline resistance in Helicobacter pylori: multiple mutational changes in 16S ribosomal DNA and other genetic loci

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900277-3

7 January 2021

Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900277-3

7 January 2021

Omeprazole, furazolidone, and tetracycline: an eradication treatment for resistant H. pylori in Brazilian patients with peptic ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900277-3

7 January 2021

Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900277-3

7 January 2021

Effects of 16S rRNA gene mutations on tetracycline resistance in Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900277-3

7 January 2021

The complete genome sequence of the gastric pathogen Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900277-3

7 January 2021

Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900277-3

7 January 2021

A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900277-3

7 January 2021

10.1016/S0928-8244(03)00277-3

Identifiers

DOI

1 reference

5 December 2017

1 reference